首页> 外文OA文献 >Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients

【2h】

Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients

机译：白细胞介素-2受体抗体不会降低低免疫风险或他克莫司治疗的中度免疫风险肾移植受者的排斥风险

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
WAI H LIM; STEVE J CHADBAN; SCOTT CAMPBELL; HANNAH DENT; GRAEME R RUSS; STEPHEN P MCDONALD;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients. [J] . Lim WH, Chadban SJ, Campbell S, Nephrology. . 2010,第3期

机译：白细胞介素2受体抗体不能降低低免疫风险或他克莫司治疗的中度免疫风险肾移植受者的排斥风险。
2. Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study [J] . Gatault P., Kamar N., Buchler M., American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons . 2017,第5期

机译：低免疫风险肾移植受者的延长释放的立唑蛋白剂量减少增加了供体特异性抗体的抑制和外观的风险：随机研究
3. Effect of interleukin-2 receptor antibody therapy on acute rejection risk and severity, long-term renal function, infection and malignancy-related mortality in renal transplant recipients. [J] . Lim W, Chadban S, Campbell S, Transplant international : . 2010,第12期

机译：白细胞介素2受体抗体治疗对肾移植受者急性排斥反应的风险和严重程度，长期肾功能，感染和恶性肿瘤相关死亡率的影响。
4. TREATMENT OF REFRACTORY ANTIBODY MEDIATED REJECTION WITH BORTEZOMIB IN TWO TRANSPLANT RECIPIENTS: THE IMPACT ON DONOR-SPECIFIC ANTI-HLA ANTIBODIES [C] . John Lunz, Judy Howe, Lawrence Jelinek, Clinical Histocompatibility Workshop. . 2010

机译：治疗难治性抗体在两个移植受者中用硼替佐米介导的抑制剂：对供体特异性抗HLA抗体的影响
5. Circulating B Cells with Memory and Antibody-Secreting Phenotypes Are Detectable in Pediatric Kidney Transplant Recipients Before the Development of Antibody-Mediated Rejection [D] . Fischman, Clara. 2019

机译：在发育抗体介导的排斥之前，在儿科肾移植受者中可检测到具有记忆和抗体分泌表型的循环B细胞
6. Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients [O] . Mysore K. Phanish, Richard P. Hull, Peter A. Andrews, 2020

机译：肾移植受者的免疫学风险分层和量身定制的免疫抑制最小化
7. Effect of interleukin-2 receptor antibody therapy on acute rejection risk and severity, long-term renal function, infection and malignancy-related mortality in renal transplant recipients [O] . Lim W., Chadban S., Dent H., 2010

机译：白细胞介素-2受体抗体治疗对肾移植受者急性排斥风险和严重程度，长期肾功能，感染和恶性肿瘤相关死亡率的影响

Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients

著录项

引文网络

相似文献

相关主题

期刊订阅